Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Masashi Taki"'
Autor:
Yuji Kashiwakura, Nemekhbayar Baatartsogt, Shoji Yamazaki, Azusa Nagao, Kagehiro Amano, Nobuaki Suzuki, Tadashi Matsushita, Akihiro Sawada, Satoshi Higasa, Naoya Yamasaki, Teruhisa Fujii, Taemi Ogura, Hideyuki Takedani, Masashi Taki, Takeshi Matsumoto, Jun Yamanouchi, Michio Sakai, Masako Nishikawa, Yutaka Yatomi, Koji Yada, Keiji Nogami, Ryota Watano, Takafumi Hiramoto, Morisada Hayakawa, Nobuhiko Kamoshita, Akihiro Kume, Hiroaki Mizukami, Shizukiyo Ishikawa, Yoichi Sakata, Tsukasa Ohmori
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 27, Iss , Pp 404-414 (2022)
Adeno-associated virus (AAV) vectors are promising modalities of gene therapy to address unmet medical needs. However, anti-AAV neutralizing antibodies (NAbs) hamper the vector-mediated therapeutic effect. Therefore, NAb prevalence in the target popu
Externí odkaz:
https://doaj.org/article/b43dde9c693b47fc933baa57f7dd8461
Autor:
Takashi Suzuki, Kenji Nishio, Tadashi Matsushita, Kenichi Ogiwara, Masashi Taki, Hideyuki Takedani, Kagehiro Amano, Masanori Matsumoto, Midori Shima, Masato Kasahara, Keiji Nogami
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/3227710953b2469bb28e002e48de88f2
Autor:
Midori Shima, Hideji Hanabusa, Masashi Taki, Tadashi Matsushita, Tetsuji Sato, Katsuyuki Fukutake, Ryu Kasai, Koichiro Yoneyama, Hiroki Yoshida, Keiji Nogami
Publikováno v:
Blood Advances, Vol 1, Iss 22, Pp 1891-1899 (2017)
Abstract: Emicizumab (ACE910), a recombinant humanized bispecific monoclonal antibody, provides factor VIII (FVIII) cofactor bridging function to restore hemostasis in people with hemophilia A. In a phase 1 trial involving 18 Japanese patients with s
Externí odkaz:
https://doaj.org/article/89b9e28a8cf9462090bdaf773a62bd5e
Publikováno v:
Allergology International, Vol 46, Iss 4, Pp 255-260 (1997)
The influence of azelastine (AZ) on murine mast cell induction was examined by in vitro cell culture techniques. Splenocytes from normal BALB/c mice suspended in RPMI-1640 medium supplemented with interleukin-3 were cultured in the presence or absenc
Externí odkaz:
https://doaj.org/article/858691ad58c54d249d5c30ed44243aea
Autor:
Michio, Sakai, Kagehiro, Amano, Motoaki, Chin, Hideyuki, Takedani, Hiroyuki, Ishida, Kazuo, Sakashita, Masashi, Taki, Masahiro, Migita, Hiroyoshi, Watanabe, Masataka, Ishimura, Keiji, Nogami, Sho, Harano, Akira, Shirahata
Publikováno v:
Haemophilia. 29:456-465
Haemophilia B patients with factor IX inhibitors have particularly unmet needs for conventional therapy.Phase II/III clinical trial, multicentre, open-label, prospective, self-controlled study was conducted to assess MC710 prophylaxis in haemophilia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e1c65c90ce903df3219d302404ae8a3
https://doi.org/10.1111/hae.14710
https://doi.org/10.1111/hae.14710
Autor:
Mari Minatogawa, Takuya Hirose, Shuji Mizumoto, Tomomi Yamaguchi, Chiai Nagae, Masashi Taki, Shuhei Yamada, Takafumi Watanabe, Tomoki Kosho
Publikováno v:
Human Mutation. 43:1829-1836
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d5b998862ad68dd9cbd6a0dfa7a8e63
https://doi.org/10.1002/humu.24437
https://doi.org/10.1002/humu.24437
Autor:
Midori Shima, Hideyuki Takedani, Kaoru Kitsukawa, Masashi Taki, Akira Ishiguro, Azusa Nagao, Daisuke Nosaka, Yui Kyogoku, Keisuke Iwasaki, Keiji Nogami
Publikováno v:
Blood. 140:2742-2744
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d35e17df4ed6b83f2da7aea9c433870
https://doi.org/10.1182/blood-2022-157249
https://doi.org/10.1182/blood-2022-157249
Publikováno v:
Journal of St. Marianna University. 13:39-43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdaca54a96cc15714dec7caf72aff5e8
https://doi.org/10.17264/stmarieng.13.39
https://doi.org/10.17264/stmarieng.13.39
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 33:60-68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b8c2e8159db0e1e52d782e4c504be71
https://doi.org/10.2491/jjsth.33.60
https://doi.org/10.2491/jjsth.33.60
Autor:
Midori Shima, Hideyuki Takedani, Kaoru Kitsukawa, Masashi Taki, Akira Ishiguro, Azusa Nagao, Haruko Yamaguchi-Suita, Yui Kyogoku, Seitaro Yoshida, Keiji Nogami
Publikováno v:
BMJ open. 12(6)
IntroductionPersons with haemophilia A (PwHA) commonly experience regular bleeding into joints, which may result in joint damage and complications such as degenerative arthritis. Emicizumab has previously demonstrated efficacy in reducing the occurre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3db7549c02d8a6b30fee8fdd7c4d4754
https://pubmed.ncbi.nlm.nih.gov/35697445
https://pubmed.ncbi.nlm.nih.gov/35697445